X0303 4 2009-04-07 0000827809 QLT INC/BC QLTI 0001451330 NB Public Equity K/S OSTERGADE 5, 3RD FLOOR DK-1100 COPENHAGEN K G7 DENMARK 0 0 1 0 0001360573 Hansen Christian OSTERGADE 5, 3RD FLOOR DK-1100 COPENHAGEN K G7 DENMARK 0 0 1 0 0001360509 Schonharting Florian OSTERGADE 5, 3RD FLOOR DK-1100 COPENHAGEN K G7 DENMARK 0 0 1 0 Common Shares, no par value 2009-04-07 4 P 0 900 1.815 A 9184472 D Common Shares, no par value 2009-04-07 4 P 0 8900 1.82 A 9193372 D Common Shares, no par value 2009-04-07 4 P 0 4000 1.825 A 9197372 D Common Shares, no par value 2009-04-07 4 P 0 16476 1.83 A 9213848 D Common Shares, no par value 2009-04-07 4 P 0 1500 1.835 A 9215348 D Common Shares, no par value 2009-04-07 4 P 0 19888 1.84 A 9235236 D Common Shares, no par value 2009-04-07 4 P 0 3226 1.845 A 9238462 D Common Shares, no par value 2009-04-07 4 P 0 198369 1.85 A 9436831 D Common Shares, no par value 2009-04-08 4 P 0 1200 1.88 A 9438031 D Common Shares, no par value 2009-04-08 4 P 0 600 1.8825 A 9438631 D Common Shares, no par value 2009-04-08 4 P 0 2400 1.885 A 9441031 D Common Shares, no par value 2009-04-08 4 P 0 17782 1.89 A 9458813 D Common Shares, no par value 2009-04-08 4 P 0 200 1.895 A 9459013 D Common Shares, no par value 2009-04-08 4 P 0 60852 1.90 A 9519865 D Reported shares are owned directly by NB Public Equity K/S (the "Fund"), and indirectly by the other listed Reporting Owners. Christian Hansen and Florian Sch?nharting are direct investors in a limited partner in the Fund and directors of Nordic Biotech Advisors ApS, which owns 100% of the shares of NB Public Equity Komplementar ApS, the general partner of the Fund. Each of Messrs. Hansen and Sch?nharting disclaim beneficial ownership in the securities, except to the extent of their pecuniary interest therein. /s/ Erin M. Gossett, as attorney-in-fact 2009-04-09